A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Clinical trial NCT03484520 · TERMINATED

Trial details

NCT number: NCT03484520
Sponsor: AbbVie
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer - Acute Myeloid Leukemia

Start date: 2018-07-23
Primary completion: 2022-12-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.